Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic Intervention

28 Jun 2023

Abstract excerpt

MicroRNAs (miRNAs) are small noncoding RNAs that post-transcriptionally inhibit gene expression. These small molecules are involved in several biological conditions such as inflammation, cell growth and proliferation, and regulation of energy metabolism. In the context of metabolic and cardiovascular diseases, miR-33 is of particular interest as it has been implicated in the regulation of lipid and glucose...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circular RNAs in diseases
Share to Liver Disease Diagnosis and Treatment
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37445956
DOI: 10.3390/ijms241310777

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic InterventionPMID 37445956Read ↗

MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in miceSemantic proximity Read ↗

Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin Resistance.Semantic proximity Read ↗

miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular DiseaseSemantic proximity Read ↗

Therapeutic Inhibition of miR-33 Promotes Fatty Acid Oxidation but Does Not Ameliorate Metabolic Dysfunction in Diet-Induced Obesity.Semantic proximity Read ↗

miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progressionSemantic proximity Read ↗

MicroRNAs in metabolic dysfunction‐associated diseases: Pathogenesis and therapeutic opportunitiesSemantic proximity Read ↗

MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivoSemantic proximity Read ↗

SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic StrategiesSemantic proximity Read ↗

Inflammation-related miRNAs in obesity, CVD, and NAFLDSemantic proximity Read ↗

The potential role of miR-27a and miR-320a in metabolic syndrome in obese Egyptian femalesSemantic proximity Read ↗

Effects of Phytosterol Supplementation on miR-33a/b Expression in Human Cell LinesSemantic proximity Read ↗

Aberrant expression of plasma microRNA-33a in an atherosclerosis-risk group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.